Literature DB >> 16306372

Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice.

So-Young Park1, You-Ree Cho, Hyo-Jeong Kim, Takamasa Higashimori, Cheryl Danton, Mi-Kyung Lee, Asim Dey, Beverly Rothermel, Young-Bum Kim, April Kalinowski, Kerry S Russell, Jason K Kim.   

Abstract

Type 2 diabetes is a heterogeneous disease characterized by insulin resistance and altered glucose and lipid metabolism in multiple organs. To understand the complex series of events that occur during the development of obesity-associated diabetes, we examined the temporal pattern of changes in insulin action and glucose metabolism in individual organs during chronic high-fat feeding in C57BL/6 mice. Insulin-stimulated cardiac glucose metabolism was significantly reduced after 1.5 weeks of high-fat feeding, and cardiac insulin resistance was associated with blunted Akt-mediated insulin signaling and GLUT4 levels. Insulin resistance in skeletal muscle, adipose tissue, and liver developed in parallel after 3 weeks of high-fat feeding. Diet-induced whole-body insulin resistance was associated with increased circulating levels of resistin and leptin but unaltered adiponectin levels. High-fat feeding caused insulin resistance in skeletal muscle that was associated with significantly elevated intramuscular fat content. In contrast, diet-induced hepatic insulin resistance developed before a marked increase in intrahepatic triglyceride levels. Cardiac function gradually declined over the course of high-fat feeding, and after 20 weeks of high-fat diet, cardiac dysfunction was associated with mild hyperglycemia, hyperleptinemia, and reduced circulating adiponectin levels. Our findings demonstrate that cardiac insulin resistance is an early adaptive event in response to obesity and develops before changes in whole-body glucose homeostasis. This suggests that obesity-associated defects in cardiac function may not be due to insulin resistance per se but may be attributable to chronic alteration in cardiac glucose and lipid metabolism and circulating adipokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306372     DOI: 10.2337/diabetes.54.12.3530

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  127 in total

1.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

2.  TRPM2 Ca2+ channel regulates energy balance and glucose metabolism.

Authors:  Zhiyou Zhang; Wenyi Zhang; Dae Young Jung; Hwi Jin Ko; Yongjin Lee; Randall H Friedline; Eunjung Lee; John Jun; Zhexi Ma; Francis Kim; Nicholas Tsitsilianos; Kathryn Chapman; Alastair Morrison; Marcus P Cooper; Barbara A Miller; Jason K Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

3.  Influence of dark phase restricted high fat feeding on myocardial adaptation in mice.

Authors:  Ju-Yun Tsai; Carolina Villegas-Montoya; Brandon B Boland; Zachary Blasier; Oluwaseun Egbejimi; Raquel Gonzalez; Michael Kueht; Tracy A McElfresh; Rachel A Brewer; Margaret P Chandler; Molly S Bray; Martin E Young
Journal:  J Mol Cell Cardiol       Date:  2012-09-29       Impact factor: 5.000

4.  Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.

Authors:  Sihem Boudina; Heiko Bugger; Sandra Sena; Brian T O'Neill; Vlad G Zaha; Olesya Ilkun; Jordan J Wright; Pradip K Mazumder; Eric Palfreyman; Timothy J Tidwell; Heather Theobald; Oleh Khalimonchuk; Benjamin Wayment; Xiaoming Sheng; Kenneth J Rodnick; Ryan Centini; Dong Chen; Sheldon E Litwin; Bart E Weimer; E Dale Abel
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

5.  Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes.

Authors:  D J Baker; A M Atkinson; G P Wilkinson; G J Coope; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

6.  Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes.

Authors:  D J Baker; G P Wilkinson; A M Atkinson; H B Jones; M Coghlan; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.

Authors:  Imene Tabbi-Anneni; Jonathan Buchanan; Robert C Cooksey; E Dale Abel
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 8.  Creating and curing fatty hearts.

Authors:  Raffay S Khan; Konstaninos Drosatos; Ira J Goldberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

9.  Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity.

Authors:  L K Stewart; Z Wang; D Ribnicky; J L Soileau; W T Cefalu; T W Gettys
Journal:  Diabetologia       Date:  2009-01-14       Impact factor: 10.122

10.  Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.

Authors:  Jordan J Wright; Jaetaek Kim; Jonathan Buchanan; Sihem Boudina; Sandra Sena; Kyriaki Bakirtzi; Olesya Ilkun; Heather A Theobald; Robert C Cooksey; Kostantin V Kandror; E Dale Abel
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.